Recombinant ITGA4 (Natalizumab Biosimilar) 抗体
Quick Overview for Recombinant ITGA4 (Natalizumab Biosimilar) 抗体 (ABIN7597845)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
质量等级
- 
    - 
                                            Expression System
- Mammalian cells
- 
                                            原理
- Research Grade Natalizumab Biosimilar Antibody
- 
                                            特异性
- ITGA4, CD49d, CD49 antigen-like family member D, CD49D, VLA-4 subunit alpha, Integrin alpha-IV, Integrin alpha-4
- 
                                            纯化方法
- Protein A or G purified from cell culture supernatant.
- 
                                            纯度
- >95 % by SDS-PAGE.
- 
                                            亚型
- IgG4 kappa
 
- 
                                            
- 
    
- 
    - 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 1 mg/mL
- 
                                            缓冲液
- 0.01M PBS, pH 7.4.
- 
                                            储存条件
- 4 °C,-20 °C,-80 °C
- 
                                            储存方法
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - ITGA4 (Natalizumab Biosimilar)
- 
                                            别名
- Natalizumab Biosimilar
- 
                                            物质类
- Biosimilar
- 
                                            背景
- ITGA4, CD49d, CD49 antigen-like family member D, CD49D, VLA-4 subunit alpha, Integrin alpha-IV, Integrin alpha-4
- 
                                            UniProt
- P13612
- 
                                            CAS-编号
- 189261-10-7
 抗原
- 
                    
 
                                     
                                     
                                    